Arf is a tumor suppressor that regulates p53 and is a frequent target for loss in human cancers. Through two novel mechanisms, Arf inhibits the oncoprotein Hdm2, which is itself a negative regulator of p53. (1) Arf sequesters Hdm2 within nucleoli and (2) Arf inhibits Hdm2-dependent E3-like ubiquitination of p53. These activities promote p53-mediated cell cycle arrest and apoptosis and are dependent on interactions between Arf and Hdm2. We will identify the domains responsible for Arf/Hdm2 interactions and study them using structural techniques. We will prepare a series of Hdm2 fragments and Arf peptides and monitor their interactions using surface plasmon resonance and circular dichroism spectroscopy. Further, we will establish assays for both Arf functions and determine the functional properties of our domains to correlate their roles in molecular interaction and function. We hypothesize that allosteric interactions between the central acidic domain and the RING domain of Hdm2 regulate both nucleolar localization and E3 activity and that Arf disrupts these interactions by binding the central Hdm2 domain. We will use the above techniques to characterize domain/domain interactions to test this model. Also, we will determine high-resolution solution structures for individual Arf and Hdm2 domains as well as their biologically relevant complexes using NMR spectroscopy. These structures will reveal the molecular basis for Arf/Hdm2 interactions and for Arf-dependent regulation of Hdm2. Since structural information for these domains is not yet available, these studies are poised to contribute novel insights into the molecular mechanisms of this unusual tumor suppressor system. Finally, Arf also functions through a p53-independent mechanism to produce cell cycle arrest. We hypothesize that Arf interacts with other nuclear proteins to produce this effect and will extend our molecular studies to these putative Arf targets; importantly, novel targets have already been identified.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA092035-03
Application #
6634075
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Gallahan, Daniel L
Project Start
2001-06-01
Project End
2006-05-31
Budget Start
2003-06-01
Budget End
2004-05-31
Support Year
3
Fiscal Year
2003
Total Cost
$217,875
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Gibbs, E B; Kriwacki, R W (2018) Direct detection of carbon and nitrogen nuclei for high-resolution analysis of intrinsically disordered proteins using NMR spectroscopy. Methods 138-139:39-46
Sivakolundu, Sivashankar G; Nourse, Amanda; Moshiach, Simon et al. (2008) Intrinsically unstructured domains of Arf and Hdm2 form bimolecular oligomeric structures in vitro and in vivo. J Mol Biol 384:240-54
Chipuk, Jerry E; Fisher, John C; Dillon, Christopher P et al. (2008) Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. Proc Natl Acad Sci U S A 105:20327-32
Pham, Truc-Chi T; Kriwacki, Richard W; Parrill, Abby L (2007) Peptide design and structural characterization of a GPCR loop mimetic. Biopolymers 86:298-310
Galea, Charles A; Pagala, Vishwajeeth R; Obenauer, John C et al. (2006) Proteomic studies of the intrinsically unstructured mammalian proteome. J Proteome Res 5:2839-48